Remove Government Remove Pharma Remove Pharmaceutical research Remove Safety
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve! The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. What are these new and existing pharma regulations, expectations, and challenges? COVID-19, Telemedicine, & The New Pharma Landscape.

Pharma 52
article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is worth mentioning that the government is the largest pharmaceutical buyer in Malaysia, responsible for more than half of the pharmaceutical purchasing value.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

This is true not only in the case of the general public using applications for creating images or text, but also for pharma companies to improve drug discovery, clinical trial recruitment, and finding new biomarkers. This action was part of the UK’s National AI Strategy of which the third pillar is “Governing AI effectively”.

Pharma 140
article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety.

Pharma 98